digital currency exchange website- Top People also ask

The Nikkei 225 index just broke through the 40000.00 mark, and the latest report was 40000.43, up 1.60% in the day.Japanese government bond futures rose, recovering some of the earlier declines.New Cape: At present, the company's revenue from AI products is not high. The new Cape said on the interactive platform on December 12 that the company actively explored in the field of artificial intelligence and gradually established its own AI corpus to support the research and development of intelligent services and products. At present, the company's AI product revenue is not high, which will not have a significant impact on the company's performance.

Japanese government bond futures rose, recovering some of the earlier declines.Bank of America Securities lowered the Adobe target price from $640.00 to $605.00.The main fuel contract rose by 6.00% in the day and is now reported at 3249.00 yuan/ton.

The Korea Composite Index closed up 1.60%.Zhongding Co., Ltd. established a subsidiary of Robotics Technology. Tianyancha APP shows that Anhui Ruisibo Robotics Technology Co., Ltd. was recently established, with Xia Yingsong as its legal representative and a registered capital of 50 million yuan. Its business scope includes: research and development of intelligent robots; Intelligent robot sales; Industrial robot manufacturing; Industrial robot sales and so on. Tianyancha's equity penetration shows that the company is wholly owned by Zhongding.The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)